Some of the key players operating in the continuous renal replacement therapy market include
Medtronic
B.Braun Melsungen
Asahi Kasei Corporation
Baxter International Inc.
Medica
Medites
Medical Components
Nikkiso
Nxtstage
Toray
Tricol Biomedical
Authors:
Mariam Faizullabhoy , Shishanka Wangnoo
Frequently Asked Questions (FAQ) :
Continuous renal replacement therapy industry size was over USD 1 billion in 2022 and is projected to expand at 6.9% CAGR from 2023 to 2032, driven by the increasing prevalence of chronic renal diseases globally.
The consumables segment is estimated to reach USD 1.3 billion by 2032 owing to the widespread adoption of high-performance hemofilters and dialyzers.
North America continuous renal replacement therapy industry size exceeded USD 371 million in 2022 and will record substantial growth through 2032 attributed to the high demand for CRRT from the expanding senior population prone to renal failure.
Some of the major companies engaged in the continuous renal replacement therapy industry are Medtronic, B.Braun Melsungen, Asahi Kasei Corporation, Baxter International Inc., Medica, Medites, Medical Components, Nikkiso, Nxtstage, Toray, and Tricol Biomedical.